[Haemodialysis in the treatment of biguanide-induced lactate acidosis (author's transl)]. 1978

P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling

Severe lactate acidosis developed in nine diabetics on biguanide. When lactate acidosis was diagnosed all patients had reduced renal function, six being oligoanuric. Pre-existing chronic renal failure as a factor in the development of lactic acidosis was excluded in five patients, normal renal function being restored later. All patients were dialysed, seven surviving. This mortality rate is lower than that reported by others for biguanide-induced lactate acidosis. Rapid biguanide elimination by dialysis was demonstrated both in vitro and in vivo. The in vivo clearance of buformin was 83 +/- 43 ml/min (mean +/- SD, n = 4), that of phenformin 68 +/- 33 ml/min (n = 7). The main advantages of haemodialysis in the treatment of biguanide-induced lactic acidosis are rapid removal of toxic biguanides and excess lactate and the ability to administer sodium bicarbonate adequately without risking hypernatraemia and fluid overload.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009846 Oliguria Decreased URINE output that is below the normal range. Oliguria can be defined as urine output of less than or equal to 0.5 or 1 ml/kg/hr depending on the age. Oligurias
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D002026 Buformin An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation. Butylbiguanide,1-Butylbiguanide,Adebit,Gliporal,Silubin,Silubin Retard,1 Butylbiguanide,Retard, Silubin
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
March 1977, Deutsche medizinische Wochenschrift (1946),
P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
January 1978, Klinische Monatsblatter fur Augenheilkunde,
P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
January 1979, Wiener klinische Wochenschrift,
P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
July 1977, Deutsche medizinische Wochenschrift (1946),
P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
June 2012, Ugeskrift for laeger,
P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
March 1978, Wiener klinische Wochenschrift,
P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
September 1990, The Journal of the Association of Physicians of India,
P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
November 1981, Klinische Wochenschrift,
P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
September 1973, Klinische Wochenschrift,
P H Althoff, and W Fassbinder, and M Neubauer, and K M Koch, and K Schöffling
July 1979, European journal of clinical pharmacology,
Copied contents to your clipboard!